TARGETING A NOVEL T-CELL INHIBITORY RECEPTOR AND DEVELOP NOVEL IMMUNOPREVENTION APPROACHES FOR MELANOMA

$1,177,500FY2022Defense Health AgencyDOD

The Cleveland Clinic Foundation

Investigators

TARGETING A NOVEL T-CELL INHIBITORY RECEPTOR AND DEVELOP NOVEL IMMUNOPREVENTION APPROACHES FOR MELANOMA · GrantIndex